Clover Health Investments Corp.
CLOV | NASDAQ
$4.56
+$0.02 (+0.44%)
Sep 22, 2026, 12:28 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -13.82 | -35.88 | -2.12 | -1.31 | -2.98 | -72.91 |
PEG Ratio | -0.15 | 0.45 | 0.06 | 0.03 | -0.01 | 0.98 |
PS Ratio | 0.63 | 1.13 | 0.36 | 0.40 | 1.19 | 10.08 |
PB Ratio | 3.94 | 4.52 | 1.60 | 1.24 | 3.27 | -10.99 |
P/FCF Ratio | -17.62 | 46.37 | -3.94 | -2.12 | -6.19 | -56.90 |
P/OCF Ratio | -18.16 | 44.30 | -3.96 | -2.17 | -6.20 | -57.24 |
OCF/S Ratio | -3.48 | 2.54 | -9.19 | -18.60 | -19.18 | -17.61 |
Debt / Equity Ratio | n/a | n/a | 0.02 | 0.02 | 0.05 | -0.22 |
Quick Ratio | 1.47 | 1.61 | 1.64 | 1.45 | 2.02 | 1.16 |
Current Ratio | 1.47 | 1.61 | 1.64 | 1.45 | 2.02 | 1.16 |
Asset Turnover | 3.56 | 2.36 | 2.21 | 1.36 | 1.55 | 2.52 |
Interest Coverage | n/a | n/a | -29.33K | -210.32 | -37.67 | -1.62 |
Return on Equity | -27.71% | -12.61% | -74.50% | -95.15% | -109.78% | 22.10% |
Return on Assets | -15.81% | -7.41% | -37.39% | -41.99% | -61.82% | -51.03% |
Return on Invested Capital | -25.75% | -12.46% | -65.98% | -75.65% | -109.59% | -72.08% |
Dividend Yield | n/a | n/a | n/a | n/a | 2.69% | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | -8.01% | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 18.49% | 26.61% | 20.30% | 9.44% | -5.38% | 12.31% |
Net Profit Margin | -4.45% | -3.14% | -16.93% | -30.97% | -39.93% | -20.27% |
Pretax Profit Margin | -4.45% | -3.37% | -16.67% | -23.22% | -39.93% | -20.27% |
Operating Profit Margin | -4.44% | -3.34% | -16.29% | -26.14% | -43.27% | -13.78% |
FCF Margin | -3.58% | 2.43% | -9.24% | -19% | -19.23% | -17.71% |
EBITDA Margin | -4.36% | -3.28% | -16.47% | -22.98% | -38.70% | -11.70% |
Add to Watchlist
Select watchlists to add or remove CLOV